Biotech · Private company
9 Meters Biopharma, Inc.
Track this companyFree. Adds 9 Meters Biopharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- LarazotidePhase 3 · Celiac DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- NM-002Phase 2 · Short Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Vurolenatide 100mg/PBOPhase 2 · Short Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Vurolenatide 50/50 mgPhase 2 · Short Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Vurolenatide 50mg/PBOPhase 2 · Short Bowel SyndromeClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome.PHASE2 · TERMINATED · started Jun 14, 2021ClinicalTrials.gov NCT04988997 · fetched Nov 12, 2026
- Proof of Concept Study in Patients With Short Bowel SyndromePHASE1_PHASE2 · UNKNOWN · started Jun 23, 2020ClinicalTrials.gov NCT04379856 · fetched Nov 12, 2026
- Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD SymptomsPHASE3 · TERMINATED · started May 29, 2019ClinicalTrials.gov NCT03569007 · fetched Nov 12, 2026